• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate (CAS No. 499785-52-3): A Comprehensive Overview

Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate, identified by the CAS number 499785-52-3, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic synthesis. This compound belongs to the benzodiazole derivatives class, which is well-known for its diverse biological activities and potential therapeutic applications. The unique structural features of Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate make it a valuable intermediate in the synthesis of more complex molecules, particularly in the development of novel drug candidates.

The molecular structure of Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate consists of a benzene ring fused with a triazole ring, which is further functionalized with an ester group at the 5-position. This configuration imparts specific electronic and steric properties to the molecule, influencing its reactivity and interaction with biological targets. The presence of the methyl group at the 1-position of the triazole ring enhances the compound's stability and solubility, making it more amenable to various synthetic transformations.

In recent years, Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate has been extensively studied for its potential applications in medicinal chemistry. One of the most promising areas of research involves its use as a building block in the synthesis of small-molecule inhibitors targeting various enzymes and receptors involved in metabolic pathways. For instance, studies have shown that derivatives of this compound exhibit inhibitory activity against enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are implicated in inflammation and oxidative stress-related diseases.

Moreover, Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate has been explored as a precursor in the development of novel antimicrobial agents. The triazole moiety is known to possess broad-spectrum antimicrobial properties due to its ability to disrupt essential cellular processes in bacteria and fungi. Researchers have leveraged this property to design new compounds that exhibit enhanced efficacy against drug-resistant strains of pathogens. Preliminary studies indicate that certain derivatives of Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate demonstrate promising activity against Gram-positive and Gram-negative bacteria, as well as fungal species.

The synthesis of Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Typically, the synthesis begins with the condensation of appropriate precursors under acidic or basic catalysis to form the triazole ring. Subsequent functionalization steps introduce the ester group at the 5-position through esterification reactions. Advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions have also been employed to enhance the efficiency and selectivity of these transformations.

Recent advancements in computational chemistry have further facilitated the design and optimization of Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate derivatives. Molecular modeling studies have been instrumental in predicting binding affinities and interactions between this compound and biological targets. These insights have guided the development of more potent and selective drug candidates with improved pharmacokinetic profiles. Additionally, high-throughput screening (HTS) techniques have been utilized to rapidly identify novel analogs with enhanced biological activity.

The pharmacological profile of Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate has been evaluated through both in vitro and in vivo studies. In cell-based assays, this compound has demonstrated significant inhibitory effects on various enzymes and receptors relevant to neurological disorders such as epilepsy and anxiety disorders. The benzodiazepine-like structure suggests potential interactions with GABAergic systems, which are crucial for maintaining neuronal homeostasis. Further research is ongoing to elucidate the exact mechanisms by which this compound exerts its therapeutic effects.

Industrial-scale production of Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate presents several challenges due to its complex structure and sensitive synthetic requirements. However， advances in process chemistry have enabled more efficient and cost-effective manufacturing methods. Continuous flow reactors have been explored as a means to improve reaction yields and reduce waste generation. Additionally， green chemistry principles have been integrated into synthetic protocols to minimize environmental impact while maintaining high product quality.

The future prospects for Ethyl 1-Methyl-1H-Benzod1,2,3triazole-5-carboxylate are promising，with ongoing research aimed at expanding its applications in drug discovery and therapeutic development。 Collaborative efforts between academic institutions，pharmaceutical companies，and biotechnology firms are expected to drive innovation in this field。 As our understanding of molecular interactions continues to evolve，Ethyl 1-Methyl-1H-Benzod1，2，3triazole -5 -carboxylate is poised to play a significant role in shaping the future of medicinal chemistry。

• 467235-11-6(1H-Benzotriazole-6-carboxylicacid,1-ethyl-,methylester(9CI))
• 147137-38-0(methyl 3-methyl-3H-benzo[d][1,2,3]triazole-5-carboxylate)
• 1352217-61-8(Ethyl 1-isopropyl-1,2,3-benzotriazole-5-carboxylate)
• 305381-67-3(1-methyl-1H-1,2,3-benzotriazole-5-carboxylic acid)
• 73605-91-1(Ethyl 1H-1,2,3-benzotriazole-5-carboxylate)
• 1400644-56-5(Methyl 1-butyl-1,2,3-benzotriazole-5-carboxylate)
• 1354407-23-0(Ethyl 1-ethyl-1,2,3-benzotriazole-5-carboxylate)
• 100726-41-8((Benzotriazol-1-yl)methyl benzoate)
• 7505-59-1(1H-Benzotriazole-5-carboxylicacid, 1-acetyl-, methyl ester)
• 951558-74-0(Methyl 1-benzyl-1,2,3-benzotriazole-5-carboxylate)